Global epidemiology of invasive meningococcal disease

Population Health Metrics

Volumn 11, Issue 1, 2013, Pages

  Jafri, Rabab Z ^a   Ali, Asad ^a   Messonnier, Nancy E ^b   Tevi Benissan, Carol ^c   Durrheim, David ^d,e   Eskola, Juhani ^f   Fermon, Florence ^g   Klugman, Keith P ^h,i   Ramsay, Mary ^j   Sow, Samba ^k,l   Zhujun, Shao ^m   Bhutta, Zulfiqar A ^a   Abramson, Jon ⁿ  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c World Health Organisation   (Switzerland)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e Hunter New England Population Health   (Australia)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g MÉDECINS SANS FRONTIÈRES   (Switzerland)

^h EMORY UNIVERSITY   (United States)

ⁱ UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^j PUBLIC HEALTH ENGLAND   (United Kingdom)

^k Ministry of Health   (Mali)

^l UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^m Institute for Communicable Disease Control and Prevention China CDC   (China)

ⁿ WAKE FOREST SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Epidemiology; Invasive meningococcal disease; Meningitis; Meningitis belt; Meningococcus; Neisseria meningitidis

Indexed keywords

ANTIBIOTIC AGENT; MENINGOCOCCUS VACCINE;

BACTERIAL DISEASE; DISEASE CONTROL; DISEASE PREVALENCE; ENDEMIC SPECIES; EPIDEMIOLOGY; INVASIVE SPECIES; PNEUMONIA;

ANTIBIOTIC THERAPY; AUSTRALIA; COUGHING; DISEASE TRANSMISSION; ENDEMIC DISEASE; EPIDEMIC; EPIDEMIOLOGICAL DATA; EUROPE; EVIDENCE BASED PRACTICE; FATALITY; HUMIDITY; INCIDENCE; MENINGITIS; MENINGOCOCCOSIS; MONGOLIA; NEISSERIA MENINGITIDIS; NEW ZEALAND; NORTH AMERICA; PRIORITY JOURNAL; REVIEW; SAUDI ARABIA; SOUTH AFRICA; SOUTHEAST ASIA; SOUTHERN EUROPE; SUDAN; VACCINATION; WESTERN HEMISPHERE;

AFRICA; AUSTRALIA;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS;

EID: 84883710263     PISSN: None     EISSN: 14787954     Source Type: Journal    
DOI: 10.1186/1478-7954-11-17     Document Type: Review

References (52)

1. Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol 2012, 799:1-20.
2. Epidemics of meningococcal disease. African meningitis belt, 2001. Wkly Epidemiol Rec 2001, 76:282-288.
3. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10:317-328.
4. Greenwood BM. The epidemiology of acute bacterial meningitis in tropical Africa. Bacterial meningitis 1987, 61-91. London: Academic Press, Williams JD, Burnie J.
5. Lapeyssonnie L. [Cerebrospinal Meningitis in Africa]. Bull World Health Organ 1963, 28 Suppl:1-114.
6. Harrison LH, Pelton SI, Wilder-Smith A, Holst J, Safadi MA, Vazquez JA, Taha MK, LaForce FM, von Gottberg A, Borrow R, Plotkin SA. The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine 2011, 29:3363-3371.
7. Meningococcal Vaccines: WHO position paper, November 2011. Weekly Epidemiological Record 2011, 521-540.
8. Gaspar M, Leite F, Brumana L, Felix B, Stella AA. Epidemiology of meningococcal meningitis in Angola, 1994-2000. Epidemiol Infect 2001, 127:421-424.
9. Molesworth AM, Thomson MC, Connor SJ, Cresswell MP, Morse AP, Shears P, Hart CA, Cuevas LE. Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg 2002, 96:242-249.
10. Epidemics of Meningococcal Disease, African Meningitis Belt, 2001. Wkly Epidemiol Rec 2001, 76:281-288.
11. Raghunathan PL, Jones JD, Tiendrebeogo SR, Sanou I, Sangare L, Kouanda S, Dabal M, Lingani C, Elie CM, Johnson S, et al. Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002. J Infect Dis 2006, 193:607-616.
12. WHO Meningitis season 2007-2008: moderate levels of meningitis activity. Global Alert and Response-Disease Outbreak News 2008, Geneva: Wold Health Organisation, WHO.
13. 2001 - Meningococcal disease in the African Meningitis Belt - Update 3. Global Alert and Response-Disease Outbreak News 2001, Geneva: World Health Organisation.
14. Meningococcal disease in the African Meningitis Belt, epidemic season 2006. Global Alert and Response-Disease Outbreak News 2006, World Health Organisation.
15. Expanded Program on Immunization (EPI). Wkly Epidemiol Rec 1997, 72:109-116.
16. Epidemic meningococcal disease--Kenya and Tanzania: recommendations for travelers, 1990. MMWR Morb Mortal Wkly Rep 1990, 39:13-14.
17. Boisier P, Nicolas P, Djibo S, Taha MK, Jeanne I, Mainassara HB, Tenebray B, Kairo KK, Giorgini D, Chanteau S. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis 2007, 44:657-663.
18. WHO Meningococcal disease in Saudi Arabia and the Netherlands - Update. Global Alert and Response-Disease Outbreak News 2000, World Health Organisation, WHO.
19. Safadi MA, Cintra OA. Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention. Neurol Res 2010, 32:263-271.
20. Baker MG, Martin DR, Kieft CE, Lennon D. A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000. J Paediatr Child Health 2001, 37:S13-S19.
21. Mendsaikhan J, Watt JP, Mansoor O, Suvdmaa N, Edmond K, Litt DJ, Nymadawa P, Baoping Y, Altantsetseg D, Slack M. Childhood bacterial meningitis in Ulaanbaatar, Mongolia, 2002-2004. Clin Infect Dis 2009, 48(Suppl 2):S141-S146.
22. von Gottberg A, du Plessis M, Cohen C, Prentice E, Schrag S, de Gouveia L, Coulson G, de Jong G, Klugman K. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis 2008, 46:377-386.
23. Annual Epidemiological Report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data 2013, Stockholm: European Centre for Disease Prevention and Control.
24. Trotter CL, Chandra M, Cano R, Larrauri A, Ramsay ME, Brehony C, Jolley KA, Maiden MC, Heuberger S, Frosch M. A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev 2007, 31:27-36.
25. Kafetzis DA, Stamboulidis KN, Tzanakaki G, Kourea Kremastinou J, Skevaki CL, Konstantopoulos A, Tsolia M. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians. Clin Microbiol Infect 2007, 13:550-552.
26. Muscat M, Spiteri G, Calleja N, Haider J, Gray SJ, Melillo JM, Mamo J, Cuschieri P. Invasive meningococcal disease in Malta: an epidemiological overview, 1994-2007. J Med Microbiol 2009, 58:1492-1498.
27. Iversen BG, Aavitsland P. Meningococcal disease in Norway 1992-1995. Epidemiology and fatality. Scand J Infect Dis 1996, 28:253-259.
28. Meningococcal Disease [http://ec.europa.eu/health/ph_information/dissemination/echi/docs/meningoccocal_en.pdf].
29. Dickinson FO, Perez AE. Bacterial meningitis in children and adolescents: an observational study based on the national surveillance system. BMC Infect Dis 2005, 5:103.
30. Guidelines for the early clinical and public health management of meningococcal disease in Australia. - Revised Edition 2007 2007, Communicable Diseases Network Australia: Commonwealth Department of Health and Ageing.
31. Efron AM, Sorhouet C, Salcedo C, Abad R, Regueira M, Vazquez JA. W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina. J Clin Microbiol 2009, 47:1979-1980.
32. Whalen CM, Hockin JC, Ryan A, Ashton F. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. JAMA 1995, 273:390-394.
33. Bettinger JA, Scheifele DW, Le Saux N, Halperin SA, Vaudry W, Tsang R. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada. Pediatr Infect Dis J 2009, 28:220-224.
34. MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MC, Stuart JM. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis 2006, 12:950-957.
35. Bae SM, Kang YH. Serological and genetic characterization of meningococcal isolates in Korea. Jpn J Infect Dis 2008, 61:434-437.
36. Vyse A, Wolter JM, Chen J, Ng T, Soriano-Gabarro M. Meningococcal disease in Asia: an under-recognized public health burden. Epidemiol Infect 2011, 1-19.
37. Hu X. Surveillance of epidemiological features for epidemic cerebrospinal meningitis in China during 1980s. Zhonghua Liu Xing Bing Xue Za Zhi 1990, 11:321-324.
38. Shao Z, Li W, Ren J, Liang X, Xu L, Diao B, Li M, Lu M, Ren H, Cui Z, et al. Identification of a new Neisseria meningitidis serogroup C clone from Anhui province, China. Lancet 2006, 367:419-423.
39. Infectious Agents Surveillance Report. Meningococcal meningitis, 1999-2004, Japan http://idsc.nih.go.jp/iasr/26/300/tpc300.html. (Report IAS ed., vol. 26. pp. 33-34; 2005:33-34.
40. Weekly Infectious Disease Bulletin-Ministry of Health, Singapore http://www.moh.gov.sg/content/dam/moh_web/Statistics/Infectious_Diseases_Bulletin/2011/December/2011_week_49.pdf. 2011.
41. Wilder-Smith A, Goh KT, Barkham T, Paton NI. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin Infect Dis 2003, 36:679-683.
42. Wang JL, Liu DP, Yen JJ, Yu CJ, Liu HC, Lin CY, Chang SC. Clinical features and outcome of sporadic serogroup W135 disease Taiwan. BMC Infect Dis 2006, 6:7.
43. Greenwood BM, Blakebrough IS, Bradley AK, Wali S, Whittle HC. Meningococcal disease and season in sub-Saharan Africa. Lancet 1984, 1:1339-1342.
44. Bishai DM, Champion C, Steele ME, Thompson L. Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa. Health Aff (Millwood) 2011, 30:1058-1064.
45. Xie O, Pollard AJ, Mueller JE, Norheim G. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine. Vaccine 2013, 31:2852-2861.
46. Sinclair D, Preziosi MP, Jacob John T, Greenwood B. The epidemiology of meningococcal disease in India. Trop Med Int Health 2010, 15:1421-1435.
47. Dell E, Bedford D, McMahon B, Nicholson A. Meningococcal disease--management of serogroup C clusters in a hyperendemic area. Ir Med J 2001, 94(166):168-169.
48. Annual report of the Australian Meningococcal Surveillance Programme, 2009. Commun Dis Intell 2010, 34:291-302.
49. Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients. Pediatrics 2005, 116:496-505.
50. Campagne G, Schuchat A, Djibo S, Ousseini A, Cisse L, Chippaux JP. Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bull World Health Organ 1999, 77:499-508.
51. Peltola H, Kataja JM, Makela PH. Shift in the age-distribution of meningococcal disease as predictor of an epidemic?. Lancet 1982, 2:595-597.
52. Cartwright K, Noah N, Peltola H. Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000. Vaccine 2001, 19:4347-4356.